173 related articles for article (PubMed ID: 30143077)
1. Psoriasis Plays a Wild CARD.
Van Nuffel E; Afonina IS; Beyaert R
J Invest Dermatol; 2018 Sep; 138(9):1903-1905. PubMed ID: 30143077
[TBL] [Abstract][Full Text] [Related]
2. CARD14 Gain-of-Function Mutation Alone Is Sufficient to Drive IL-23/IL-17-Mediated Psoriasiform Skin Inflammation In Vivo.
Mellett M; Meier B; Mohanan D; Schairer R; Cheng P; Satoh TK; Kiefer B; Ospelt C; Nobbe S; Thome M; Contassot E; French LE
J Invest Dermatol; 2018 Sep; 138(9):2010-2023. PubMed ID: 29689250
[TBL] [Abstract][Full Text] [Related]
3. PSORS2 is due to mutations in CARD14.
Jordan CT; Cao L; Roberson ED; Pierson KC; Yang CF; Joyce CE; Ryan C; Duan S; Helms CA; Liu Y; Chen Y; McBride AA; Hwu WL; Wu JY; Chen YT; Menter A; Goldbach-Mansky R; Lowes MA; Bowcock AM
Am J Hum Genet; 2012 May; 90(5):784-95. PubMed ID: 22521418
[TBL] [Abstract][Full Text] [Related]
4. Rare and common variants in CARD14, encoding an epidermal regulator of NF-kappaB, in psoriasis.
Jordan CT; Cao L; Roberson ED; Duan S; Helms CA; Nair RP; Duffin KC; Stuart PE; Goldgar D; Hayashi G; Olfson EH; Feng BJ; Pullinger CR; Kane JP; Wise CA; Goldbach-Mansky R; Lowes MA; Peddle L; Chandran V; Liao W; Rahman P; Krueger GG; Gladman D; Elder JT; Menter A; Bowcock AM
Am J Hum Genet; 2012 May; 90(5):796-808. PubMed ID: 22521419
[TBL] [Abstract][Full Text] [Related]
5. Gain of function p.E138A alteration in Card14 leads to psoriasiform skin inflammation and implicates genetic modifiers in disease severity.
Sundberg JP; Pratt CH; Silva KA; Kennedy VE; Qin W; Stearns TM; Frost J; Sundberg BA; Bowcock AM
Exp Mol Pathol; 2019 Oct; 110():104286. PubMed ID: 31323190
[TBL] [Abstract][Full Text] [Related]
6. Gain-of-Function Mutation of Card14 Leads to Spontaneous Psoriasis-like Skin Inflammation through Enhanced Keratinocyte Response to IL-17A.
Wang M; Zhang S; Zheng G; Huang J; Songyang Z; Zhao X; Lin X
Immunity; 2018 Jul; 49(1):66-79.e5. PubMed ID: 29980436
[TBL] [Abstract][Full Text] [Related]
7. Whole exome sequencing approach to childhood onset familial erythrodermic psoriasis unravels a novel mutation of CARD14 requiring unusual high doses of ustekinumab.
Signa S; Campione E; Rusmini M; Chiesa S; Grossi A; Omenetti A; Caorsi R; Viglizzo GM; Galluzzo M; Bianchi L; Talamonti M; Orlandi A; Martini A; Ceccherini I; Gattorno M
Pediatr Rheumatol Online J; 2019 Jul; 17(1):38. PubMed ID: 31286971
[TBL] [Abstract][Full Text] [Related]
8. CARD14-Mediated Activation of Paracaspase MALT1 in Keratinocytes: Implications for Psoriasis.
Van Nuffel E; Schmitt A; Afonina IS; Schulze-Osthoff K; Beyaert R; Hailfinger S
J Invest Dermatol; 2017 Mar; 137(3):569-575. PubMed ID: 27939769
[TBL] [Abstract][Full Text] [Related]
9. The IL-23/T17 pathogenic axis in psoriasis is amplified by keratinocyte responses.
Lowes MA; Russell CB; Martin DA; Towne JE; Krueger JG
Trends Immunol; 2013 Apr; 34(4):174-81. PubMed ID: 23291100
[TBL] [Abstract][Full Text] [Related]
10. Clinical and Genetic Heterogeneity of
Israel L; Mellett M
Front Immunol; 2018; 9():2239. PubMed ID: 30386326
[TBL] [Abstract][Full Text] [Related]
11. CARD14 alterations in Tunisian patients with psoriasis and further characterization in European cohorts.
Ammar M; Jordan CT; Cao L; Lim E; Bouchlaka Souissi C; Jrad A; Omrane I; Kouidhi S; Zaraa I; Anbunathan H; Mokni M; Doss N; Guttman-Yassky E; El Gaaied AB; Menter A; Bowcock AM
Br J Dermatol; 2016 Feb; 174(2):330-7. PubMed ID: 26358359
[TBL] [Abstract][Full Text] [Related]
12. A novel mutation in a CARD14-associated papulosquamous eruption.
Li N; Tao J; Zhang J; Liu Z; Yu P
Pediatr Dermatol; 2023; 40(4):706-709. PubMed ID: 36724903
[TBL] [Abstract][Full Text] [Related]
13. Activating CARD14 Mutations Are Associated with Generalized Pustular Psoriasis but Rarely Account for Familial Recurrence in Psoriasis Vulgaris.
Berki DM; Liu L; Choon SE; David Burden A; Griffiths CEM; Navarini AA; Tan ES; Irvine AD; Ranki A; Ogo T; Petrof G; Mahil SK; Duckworth M; Allen MH; Vito P; Trembath RC; McGrath J; Smith CH; Capon F; Barker JN
J Invest Dermatol; 2015 Dec; 135(12):2964-2970. PubMed ID: 26203641
[TBL] [Abstract][Full Text] [Related]
14. CARD14 expression in dermal endothelial cells in psoriasis.
Harden JL; Lewis SM; Pierson KC; Suárez-Fariñas M; Lentini T; Ortenzio FS; Zaba LC; Goldbach-Mansky R; Bowcock AM; Lowes MA
PLoS One; 2014; 9(11):e111255. PubMed ID: 25369198
[TBL] [Abstract][Full Text] [Related]
15. The paracaspase MALT1 mediates CARD14-induced signaling in keratinocytes.
Afonina IS; Van Nuffel E; Baudelet G; Driege Y; Kreike M; Staal J; Beyaert R
EMBO Rep; 2016 Jun; 17(6):914-27. PubMed ID: 27113748
[TBL] [Abstract][Full Text] [Related]
16. Case of generalized pustular psoriasis with coexisting mutations in IL36RN and CARD14.
Sawabe Y; Hayashi K; Kamata M; Nagata M; Fukaya S; Fukuyasu A; Tanaka T; Ishikawa T; Ohnishi T; Komatsu H; Tanaka M; Sugiura K; Tada Y
J Dermatol; 2019 Oct; 46(10):e368-e370. PubMed ID: 31062396
[No Abstract] [Full Text] [Related]
17. Clinical response of CARD14-associated papulosquamous eruption to an anti-interleukin-17A antibody.
Klein B; Treudler R; Dumann K; Boldt A; Schumann I; Simon JC; Kunz M
Br J Dermatol; 2022 Sep; 187(3):419-422. PubMed ID: 35262907
[TBL] [Abstract][Full Text] [Related]
18. Autosomal dominant familial generalized pustular psoriasis caused by a CARD14 mutation.
Takeichi T; Kobayashi A; Ogawa E; Okuno Y; Kataoka S; Kono M; Sugiura K; Okuyama R; Akiyama M
Br J Dermatol; 2017 Oct; 177(4):e133-e135. PubMed ID: 28295164
[No Abstract] [Full Text] [Related]
19. The genetic background of generalized pustular psoriasis: IL36RN mutations and CARD14 gain-of-function variants.
Sugiura K
J Dermatol Sci; 2014 Jun; 74(3):187-92. PubMed ID: 24656634
[TBL] [Abstract][Full Text] [Related]
20. Association of CARD14 Single-Nucleotide Polymorphisms with Psoriasis.
Suleman S; Chhabra G; Raza R; Hamid A; Qureshi JA; Ahmad N
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
